These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Mucosal immunoglobulin-A and -G responses to oncogenic human papilloma virus capsids. Sasagawa T, Rose RC, Azar KK, Sakai A, Inoue M. Int J Cancer; 2003 Apr 10; 104(3):328-35. PubMed ID: 12569556 [Abstract] [Full Text] [Related]
5. Specific serum IgG, IgM and IgA antibodies to human papillomavirus types 6, 11, 16, 18 and 31 virus-like particles in human immunodeficiency virus-seropositive women. Petter A, Heim K, Guger M, Ciresa-Kö Nig A, Christensen N, Sarcletti M, Wieland U, Pfister H, Zangerle R, Höpfl R. J Gen Virol; 2000 Mar 10; 81(Pt 3):701-8. PubMed ID: 10675407 [Abstract] [Full Text] [Related]
7. Mapping of linear epitopes of human papillomavirus type 16: the L1 and L2 open reading frames. Dillner J, Dillner L, Utter G, Eklund C, Rotola A, Costa S, DiLuca D. Int J Cancer; 1990 Mar 15; 45(3):529-35. PubMed ID: 1689705 [Abstract] [Full Text] [Related]
10. A prospective study of antibody responses to defined epitopes of human papillomavirus (HPV) type 16 in relationship to genital and anorectal presence of HPV DNA. Van Doornum GJ, Prins M, Pronk L, Coutinho RA, Dillner J. Clin Diagn Lab Immunol; 1994 Nov 15; 1(6):633-9. PubMed ID: 8556513 [Abstract] [Full Text] [Related]
12. Antibodies against human papillomavirus type 6 capsids are elevated in men with previous condylomas. Wikström A, Eklund C, von Krogh G, Lidbrink P, Dillner J. APMIS; 1997 Nov 15; 105(11):884-8. PubMed ID: 9393560 [Abstract] [Full Text] [Related]
14. Human papillomavirus type 16 capsids expose multiple type-restricted and type-common antigenic epitopes. Heino P, Skyldberg B, Lehtinen M, Rantala I, Hagmar B, Kreider JW, Kirnbauer R, Dillner J. J Gen Virol; 1995 May 15; 76 ( Pt 5)():1141-53. PubMed ID: 7537325 [Abstract] [Full Text] [Related]
15. Identification of human papillomavirus seroconversions. Wikström A, van Doornum GJ, Quint WG, Schiller JT, Dillner J. J Gen Virol; 1995 Mar 15; 76 ( Pt 3)():529-39. PubMed ID: 7897345 [Abstract] [Full Text] [Related]
18. [Feasibility of HEV vaccine as control in HPV vaccine study and comparison of serological and risk factors between HEV and HPV infection among females]. Cui J, Du J, Fei M, He W, Zhang S, You J, Si Y, Fan X, Chen W. Zhonghua Zhong Liu Za Zhi; 2014 Jun 15; 36(6):476-80. PubMed ID: 25241795 [Abstract] [Full Text] [Related]